Beijing Bionovo Medicine Development Co., Ltd.
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
78%
7 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.
Role: collaborator
Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema
Role: collaborator
A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.
Role: collaborator
A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.
Role: collaborator
A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.
Role: collaborator
Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis
Role: collaborator
Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.
Role: collaborator
Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations
Role: collaborator
Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease
Role: collaborator
All 9 trials loaded